ISLAND PHARMACEUTICALS LIMITEDISLAND PHARMACEUTICALS LIMITEDISLAND PHARMACEUTICALS LIMITED

ISLAND PHARMACEUTICALS LIMITED

No trades
See on Supercharts

ILA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. Its Isla101, a drug being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. The company was founded by David Foster on May 25, 2020 and is headquartered in Camberwell, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
ILA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company